Drug Profile
Filgrastim biosimilar - Claris Lifesciences
Alternative Names: Fegrast; Recombinant G-CSF - Claris LifesciencesLatest Information Update: 12 Nov 2021
Price :
$50
*
At a glance
- Originator Claris Lifesciences
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants; Recombinant proteins
- Mechanism of Action Granulocyte colony stimulating factor receptor agonists; Granulocyte colony-stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Neutropenia
Most Recent Events
- 07 Sep 2012 Launched prior to September 2012 for Neutropenia in India (SC)